 | • レポートコード：MRC2206A030 • 出版社/出版日：Persistence Market Research / 2022年3月22日 • レポート形態：英文、PDF、386ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界の酒皶治療市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症による危機分析、価格分析、需要分析・予測、疾患別（紅斑毛細血管拡張型酒皶、丘疹膿疱性酒皶、眼性酒皶、瘤腫型酒皶）分析、薬剤分類別（抗生物質、免疫抑制剤、コルチコステロイド、その他）分析、治療タイプ別（抗生物質、局所治療、点眼薬・潤滑剤、その他）分析、流通チャネル別（機関販売、小売販売、オンライン販売）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症による危機分析 ・価格分析 ・需要分析・予測 ・世界の酒皶治療市場規模：疾患別（紅斑毛細血管拡張型酒皶、丘疹膿疱性酒皶、眼性酒皶、瘤腫型酒皶） ・世界の酒皶治療市場規模：薬剤分類別（抗生物質、免疫抑制剤、コルチコステロイド、その他） ・世界の酒皶治療市場規模：治療タイプ別（抗生物質、局所治療、点眼薬・潤滑剤、その他） ・世界の酒皶治療市場規模：流通チャネル別（機関販売、小売販売、オンライン販売） ・世界の酒皶治療市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Rosacea Therapeutics Market: Scope of Report
The latest publication by Persistence Market Research on the global rosacea therapeutics market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for rosacea therapeutics products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the rosacea therapeutics market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the rosacea therapeutics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the rosacea therapeutics market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the rosacea therapeutics market offers information divided into six important segments – disease type, drug class, treatment type, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Disease Type
Erythematotelangiectatic Rosacea
Papulopustular Rosacea
Ocular Rosacea
Phymatous Rosacea
Drug Class
Antibiotics
Immunosuppressants
Corticosteroids
Others
Treatment Type
Antibiotics
Clindamycin
Erythromycin/ Clarithromycin
Metronidazole
Doxycycline
Tetracycline
Lymecycline
Minocycline
Topical Treatment
Sodium Sulfacetamide
Azelaic acid
Metronidazole
Clindamycin
Erythromycin
Tretinoin
Oxymetazoline
Isotretinoin
Tazarotene
Adapalene
Steroid Creams
Eye Drops and Lubricants
Brimonidine
Steroid Eye Drops
Artificial Tears
Other Eye Drops and Lubricants
Other Drugs Including Methotrexate and Ivermectin
Laser therapy
Route of Administration
Oral
Topical
Others
Distribution Channel
Institutional Sales
Hospitals
Specialty Clinics
Academic and Research Institutes
Retail Sales
Retail Pharmacies
Drug Stores
Online Sales
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for rosacea therapeutics over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the rosacea therapeutics market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the rosacea therapeutics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the rosacea therapeutics market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Key Success Factors
4.1. Key Product USP
4.2. Key Strategies, by Manufacturers
4.3. Pipeline assessment
4.4. Disease Epidemiology, by Region
4.5. Regulatory Scenario
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending
5.1.3. Per Capita Healthcare Expenditure Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Rising Prevalence of Diseases
5.2.2. Improving medication & treatment options
5.2.3. Awareness and growing need for aesthetics
5.2.4. Awareness about Pain Management
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. COVID19 and Impact Analysis
6.2. 2020 Market Scenario
7. Global Rosacea Therapeutics Market – Pricing Analysis
7.1. Regional Pricing Analysis By Treatment Type
7.2. Global Average Pricing Analysis Benchmark
8. Global Rosacea Therapeutics Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
8.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, by Disease Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Disease Type, 2017-2021
9.3. Current and Future Market Size (US$ Mn) and Forecast By Disease Type, 2022-2032
9.3.1. Erythematotelangiectatic Rosacea
9.3.2. Papulopustular Rosacea
9.3.3. Ocular Rosacea
9.3.4. Phymatous Rosacea
9.4. Market Attractiveness Analysis By Disease Type
10. Global Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, by Drug Class
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Drug Class, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Drug Class, 2022-2032
10.3.1. Antibiotics
10.3.2. Immunosuppressants
10.3.3. Corticosteroids
10.3.4. Others
10.4. Market Attractiveness Analysis By Drug Class
11. Global Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, by Treatment Type
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Treatment Type, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Treatment Type, 2022-2032
11.3.1. Antibiotics
11.3.1.1. Clindamycin
11.3.1.2. Erythromycin/ Clarithromycin
11.3.1.3. Metronidazole
11.3.1.4. Doxycycline
11.3.1.5. Tetracycline
11.3.1.6. Lymecycline
11.3.1.7. Minocycline
11.3.2. Topical Treatment
11.3.2.1. Sodium Sulfacetamide
11.3.2.2. Azelaic acid
11.3.2.3. Metronidazole
11.3.2.4. Clindamycin
11.3.2.5. Erythromycin
11.3.2.6. Tretinoin
11.3.2.7. Oxymetazoline
11.3.2.8. Isotretinoin
11.3.2.9. Tazarotene
11.3.2.10. Adapalene
11.3.2.11. Steroid Creams
11.3.3. Eye Drops and Lubricants
11.3.3.1. Brimonidine
11.3.3.2. Steroid Eye Drops
11.3.3.3. Artificial Tears
11.3.3.4. Other Eye Drops and Lubricants
11.3.4. Other Drugs Including Methotrexate and Ivermectin
11.3.5. Laser therapy
11.4. Market Attractiveness Analysis By Treatment Type
12. Global Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, by Route of Administration
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2017-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032
12.3.1. Oral
12.3.2. Topical
12.3.3. Others
12.4. Market Attractiveness Analysis By Route of Administration
13. Global Rosacea Therapeutics Market Analysis 2017–2021 and Forecast 2022–2032, by Distribution Channel
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2017-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2022–2032
13.3.1. Institutional Sales
13.3.1.1. Hospitals
13.3.1.2. Specialty Clinics
13.3.1.3. Academic and Research Institutes
13.3.2. Retail Sales
13.3.2.1. Retail Pharmacy
13.3.2.2. Drug Stores
13.3.3. Online Sales
14. Global Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, by Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) By Region, 2017-2021
14.3. Current Market Size (US$ Mn) and Forecast By Region, 2022-2032
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Disease Type
15.3.3. By Drug Class
15.3.4. By Treatment Type
15.3.5. By Route of Administration
15.3.6. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. Latin America Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Rest of Latin America
16.3.2. By Disease Type
16.3.3. By Drug Class
16.3.4. By Treatment Type
16.3.5. By Route of Administration
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. Europe Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Disease Type
17.3.3. By Drug Class
17.3.4. By Treatment Type
17.3.5. By Route of Administration
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints – Impact Analysis
18. South Asia and Pacific Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
18.3.1. By Country
18.3.1.1. India
18.3.1.2. ASEAN
18.3.1.3. Rest of South Asia
18.3.2. By Disease Type
18.3.3. By Drug Class
18.3.4. By Treatment Type
18.3.5. By Route of Administration
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints – Impact Analysis
19. East Asia Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Disease Type
19.3.3. By Drug Class
19.3.4. By Treatment Type
19.3.5. By Route of Administration
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints – Impact Analysis
20. Oceania Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Disease Type
20.3.3. By Drug Class
20.3.4. By Treatment Type
20.3.5. By Route of Administration
20.3.6. By Distribution Channel
20.4. Market Attractiveness Analysis
20.5. Drivers and Restraints – Impact Analysis
21. Middle East and Africa Rosacea Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
21.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. Northern Africa
21.3.1.4. South Africa
21.3.1.5. Rest of Middle East and Africa
21.3.2. By Disease Type
21.3.3. By Drug Class
21.3.4. By Treatment Type
21.3.5. By Route of Administration
21.3.6. By Distribution Channel
21.4. Market Attractiveness Analysis
21.5. Drivers and Restraints – Impact Analysis
22. Country Wise Rosacea Therapeutics Market Analysis 2021-2031
22.1. Introduction
22.1.1. Market Value Proportion Analysis, By Key Countries
22.1.2. Global Vs. Country Growth Comparison
22.1.3. Pricing Analysis
22.2. U.S. Rosacea Therapeutics Market Analysis
22.2.1. By Disease Type
22.2.2. By Drug Class
22.2.3. By Treatment Type
22.2.4. By Route of Administration
22.2.5. By Distribution Channel
22.3. Canada Rosacea Therapeutics Market Analysis
22.3.1. By Disease Type
22.3.2. By Drug Class
22.3.3. By Treatment Type
22.3.4. By Route of Administration
22.3.5. By Distribution Channel
22.4. Mexico Rosacea Therapeutics Market Analysis
22.4.1. By Disease Type
22.4.2. By Drug Class
22.4.3. By Treatment Type
22.4.4. By Route of Administration
22.4.5. By Distribution Channel
22.5. Brazil Rosacea Therapeutics Market Analysis
22.5.1. By Disease Type
22.5.2. By Drug Class
22.5.3. By Treatment Type
22.5.4. By Route of Administration
22.5.5. By Distribution Channel
22.6. Germany Rosacea Therapeutics Market Analysis
22.6.1. By Disease Type
22.6.2. By Drug Class
22.6.3. By Treatment Type
22.6.4. By Route of Administration
22.6.5. By Distribution Channel
22.7. Italy Rosacea Therapeutics Market Analysis
22.7.1. By Disease Type
22.7.2. By Drug Class
22.7.3. By Treatment Type
22.7.4. By Route of Administration
22.7.5. By Distribution Channel
22.8. France Rosacea Therapeutics Market Analysis
22.8.1. By Disease Type
22.8.2. By Drug Class
22.8.3. By Treatment Type
22.8.4. By Route of Administration
22.8.5. By Distribution Channel
22.9. U.K. Rosacea Therapeutics Market Analysis
22.9.1. By Disease Type
22.9.2. By Drug Class
22.9.3. By Treatment Type
22.9.4. By Route of Administration
22.9.5. By Distribution Channel
22.10. Spain Rosacea Therapeutics Market Analysis
22.10.1. By Disease Type
22.10.2. By Drug Class
22.10.3. By Treatment Type
22.10.4. By Route of Administration
22.10.5. By Distribution Channel
22.11. Russia Rosacea Therapeutics Market Analysis
22.11.1. By Disease Type
22.11.2. By Drug Class
22.11.3. By Treatment Type
22.11.4. By Route of Administration
22.11.5. By Distribution Channel
22.12. BENELUX Rosacea Therapeutics Market Analysis
22.12.1. By Disease Type
22.12.2. By Drug Class
22.12.3. By Treatment Type
22.12.4. By Route of Administration
22.12.5. By Distribution Channel
22.13. China Rosacea Therapeutics Market Analysis
22.13.1. By Disease Type
22.13.2. By Drug Class
22.13.3. By Treatment Type
22.13.4. By Route of Administration
22.13.5. By Distribution Channel
22.14. Japan Rosacea Therapeutics Market Analysis
22.14.1. By Disease Type
22.14.2. By Drug Class
22.14.3. By Treatment Type
22.14.4. By Route of Administration
22.14.5. By Distribution Channel
22.15. S. Korea Rosacea Therapeutics Market Analysis
22.15.1. By Disease Type
22.15.2. By Drug Class
22.15.3. By Treatment Type
22.15.4. By Route of Administration
22.15.5. By Distribution Channel
22.16. India Rosacea Therapeutics Market Analysis
22.16.1. By Disease Type
22.16.2. By Drug Class
22.16.3. By Treatment Type
22.16.4. By Route of Administration
22.16.5. By Distribution Channel
22.17. ASEAN Rosacea Therapeutics Market Analysis
22.17.1. By Disease Type
22.17.2. By Drug Class
22.17.3. By Treatment Type
22.17.4. By Route of Administration
22.17.5. By Distribution Channel
22.18. Australia Rosacea Therapeutics Market Analysis
22.18.1. By Disease Type
22.18.2. By Drug Class
22.18.3. By Treatment Type
22.18.4. By Route of Administration
22.18.5. By Distribution Channel
22.19. New Zealand Rosacea Therapeutics Market Analysis
22.19.1. By Disease Type
22.19.2. By Drug Class
22.19.3. By Treatment Type
22.19.4. By Route of Administration
22.19.5. By Distribution Channel
22.20. GCC Countries Rosacea Therapeutics Market Analysis
22.20.1. By Disease Type
22.20.2. By Drug Class
22.20.3. By Treatment Type
22.20.4. By Route of Administration
22.20.5. By Distribution Channel
22.21. Turkey Rosacea Therapeutics Market Analysis
22.21.1. By Disease Type
22.21.2. By Drug Class
22.21.3. By Treatment Type
22.21.4. By Route of Administration
22.21.5. By Distribution Channel
22.22. South Africa Rosacea Therapeutics Market Analysis
22.22.1. By Disease Type
22.22.2. By Drug Class
22.22.3. By Treatment Type
22.22.4. By Route of Administration
22.22.5. By Distribution Channel
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Brand share Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
24.3.1. Lupin Ltd
24.3.1.1. Overview
24.3.1.2. Product Portfolio
24.3.1.3. Key Financials
24.3.1.4. SWOT Analysis
24.3.1.5. Sales Footprint
24.3.1.6. Strategy Overview
24.3.2. Dr. Reddy’s Laboratories Ltd
24.3.2.1. Overview
24.3.2.2. Product Portfolio
24.3.2.3. Key Financials
24.3.2.4. SWOT Analysis
24.3.2.5. Sales Footprint
24.3.2.6. Strategy Overview
24.3.3. VIATRIS (Mylan N.V.)
24.3.3.1. Overview
24.3.3.2. Product Portfolio
24.3.3.3. Key Financials
24.3.3.4. SWOT Analysis
24.3.3.5. Sales Footprint
24.3.3.6. Strategy Overview
24.3.4. Ajanta Pharma Ltd
24.3.4.1. Overview
24.3.4.2. Product Portfolio
24.3.4.3. Key Financials
24.3.4.4. SWOT Analysis
24.3.4.5. Sales Footprint
24.3.4.6. Strategy Overview
24.3.5. Cipla Ltd
24.3.5.1. Overview
24.3.5.2. Product Portfolio
24.3.5.3. Key Financials
24.3.5.4. SWOT Analysis
24.3.5.5. Sales Footprint
24.3.5.6. Strategy Overview
24.3.6. Gary Pharmaceuticals P Limited
24.3.6.1. Overview
24.3.6.2. Product Portfolio
24.3.6.3. Key Financials
24.3.6.4. SWOT Analysis
24.3.6.5. Sales Footprint
24.3.6.6. Strategy Overview
24.3.7. Glenmark Pharmaceuticals
24.3.7.1. Overview
24.3.7.2. Product Portfolio
24.3.7.3. Key Financials
24.3.7.4. SWOT Analysis
24.3.7.5. Sales Footprint
24.3.7.6. Strategy Overview
24.3.8. Teva Pharmaceutical Industries Ltd.
24.3.8.1. Overview
24.3.8.2. Product Portfolio
24.3.8.3. Key Financials
24.3.8.4. SWOT Analysis
24.3.8.5. Sales Footprint
24.3.8.6. Strategy Overview
24.3.9. Mission Pharmacal
24.3.9.1. Overview
24.3.9.2. Product Portfolio
24.3.9.3. Key Financials
24.3.9.4. SWOT Analysis
24.3.9.5. Sales Footprint
24.3.9.6. Strategy Overview
24.3.10. Sanofi SA
24.3.10.1. Overview
24.3.10.2. Product Portfolio
24.3.10.3. Key Financials
24.3.10.4. SWOT Analysis
24.3.10.5. Sales Footprint
24.3.10.6. Strategy Overview
24.3.11. VYNE Therapeutics
24.3.11.1. Overview
24.3.11.2. Product Portfolio
24.3.11.3. Key Financials
24.3.11.4. SWOT Analysis
24.3.11.5. Sales Footprint
24.3.11.6. Strategy Overview
24.3.12. Galderma
24.3.12.1. Overview
24.3.12.2. Product Portfolio
24.3.12.3. Key Financials
24.3.12.4. SWOT Analysis
24.3.12.5. Sales Footprint
24.3.12.6. Strategy Overview
24.3.13. Bayer AG
24.3.13.1. Overview
24.3.13.2. Product Portfolio
24.3.13.3. Key Financials
24.3.13.4. SWOT Analysis
24.3.13.5. Sales Footprint
24.3.13.6. Strategy Overview
24.3.14. Bausch Health Companies Inc.
24.3.14.1. Overview
24.3.14.2. Product Portfolio
24.3.14.3. Key Financials
24.3.14.4. SWOT Analysis
24.3.14.5. Sales Footprint
24.3.14.6. Strategy Overview
24.3.15. Hovione
24.3.15.1. Overview
24.3.15.2. Product Portfolio
24.3.15.3. Key Financials
24.3.15.4. SWOT Analysis
24.3.15.5. Sales Footprint
24.3.15.6. Strategy Overview
24.3.16. PruGen Pharmaceuticals
24.3.16.1. Overview
24.3.16.2. Product Portfolio
24.3.16.3. Key Financials
24.3.16.4. SWOT Analysis
24.3.16.5. Sales Footprint
24.3.16.6. Strategy Overview
24.3.17. AbbVie, Inc.
24.3.17.1. Overview
24.3.17.2. Product Portfolio
24.3.17.3. Key Financials
24.3.17.4. SWOT Analysis
24.3.17.5. Sales Footprint
24.3.17.6. Strategy Overview
24.3.18. Eckson Labs
24.3.18.1. Overview
24.3.18.2. Product Portfolio
24.3.18.3. Key Financials
24.3.18.4. SWOT Analysis
24.3.18.5. Sales Footprint
24.3.18.6. Strategy Overview
24.3.19. Sandoz Spa
24.3.19.1. Overview
24.3.19.2. Product Portfolio
24.3.19.3. Key Financials
24.3.19.4. SWOT Analysis
24.3.19.5. Sales Footprint
24.3.19.6. Strategy Overview
24.3.20. Abigail Care Pharmaceutical
24.3.20.1. Overview
24.3.20.2. Product Portfolio
24.3.20.3. Key Financials
24.3.20.4. SWOT Analysis
24.3.20.5. Sales Footprint
24.3.20.6. Strategy Overview
24.3.21. Pfizer Inc.
24.3.21.1. Overview
24.3.21.2. Product Portfolio
24.3.21.3. Key Financials
24.3.21.4. SWOT Analysis
24.3.21.5. Sales Footprint
24.3.21.6. Strategy Overview
24.3.22. Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
24.3.22.1. Overview
24.3.22.2. Product Portfolio
24.3.22.3. Key Financials
24.3.22.4. SWOT Analysis
24.3.22.5. Sales Footprint
24.3.22.6. Strategy Overview
25. Assumptions and Acronyms Used
26. Research Methodology
Table 01: Global Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease TypeTable 02: Global Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 03: Global Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 04: Global Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 05: Global Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 06: Global Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Region
Table 07: North America Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 08: North America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 09: North America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 10: North America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 11: North America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 12: North America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 13: Latin America Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 14: Latin America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 15: Latin America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 16: Latin America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 17: Latin America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 18: Latin America Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 19: Europe Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 20: Europe Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 21: Europe Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 22: Europe Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 23: Europe Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 24: Europe Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 25: South Asia Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 26: South Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 27: South Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 28: South Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 29: South Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 30: South Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 31: East Asia Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 32: East Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 33: East Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 34: East Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 35: East Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 36: East Asia Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 37: Oceania Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 38: Oceania Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 39: Oceania Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 40: Oceania Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 41: Oceania Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 42: Oceania Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel
Table 43: MEA Rosacea Therapeutics Market Size Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 44: MEA Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Disease Type
Table 45: MEA Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Drug Class
Table 46: MEA Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Route of Administration
Table 47: MEA Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Treatment Type
Table 48: MEA Rosacea Therapeutics Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel